Form Type: 4

SEC EDGAR Link
Accession Number:0001415889-20-000055
Date:2020-01-02
Issuer: AMPIO PHARMACEUTICALS, INC. (AMPE)
Original Submission Date:

Reporting Person:

GILES RICHARD B
C/O AMPIO PHARMACEUTICALS, INC.
373 INVERNESS PARKWAY, SUITE 200 ENGLEWOOD, CO 80112

Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
Title of SecurityTransaction Date2a. Deemed Execution Date Transaction CodeSharesAcquired or DisposedPrice per share 5. Amount of Securities Beneficially Owned Following Reported Transaction 6. Ownership Form Direct or IndirectNature of Indirect Ownership
COMMON STOCK 2020-01-02 A 34,059 a $0.59 301,353 direct
COMMON STOCK 2020-01-02 0 $0.00 50,417 indirect
COMMON STOCK 2020-01-02 0 $0.00 1,838 indirect
Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, convertible securities
Title of Derivative Security Conversion or Exercise Price of Derivative Security Transaction Date Deemed Execution Date Transaction Code Number of Derivative Securities Acquired (A) or Disposed of (D) Date ExercisableExpiration Date Title and Amount of Securities Underlying Derivative Security Price of Derivative Security Number of derivative Securities Beneficially Owned Following Reported Transaction(s) Ownership Form: Direct (D) or Indirect (I) Nature of Indirect Beneficial Ownership
Footnotes
IDfootnote
f1 the shares were issued to the reporting person under the issuer's 2019 stock option and incentive plan and pursuant to compensation agreements approved by the board of directors of the issuer.
WhaleWisdom Logo

Elevate your investments